期刊文献+

银屑病75例伴发系统性疾病及其相关因素分析 被引量:1

The Analysis of 75 Psoriasis Inpatients with Systemic Diseases and Its Related Factors
下载PDF
导出
摘要 目的观察银屑病患者中系统性疾病的发生率及其相关因素。方法选取2008年1月-2012年12月本院收治的75例银屑病患者作为观察组,92例神经性皮炎患者作为对照组,用SPSS18.0统计软件对两组合并系统性疾病发的生率;以及与吸烟、饮酒及病程的相关性进行统计学分析。结果银屑病组合并有系统性疾病40例,神经性皮炎合并组系统性疾病35例,银屑病组系统性疾病发病率显著高于神经性皮炎组(P<0.05)。两组中吸烟、饮酒及病程无统计学意义(P=0.687,0.951,0.845),年龄差异有统计学意义(P=0.029)。结论银屑病与系统性疾病紧密相连,吸烟、饮酒及年龄可能为银屑病发生系统性疾病危险因素。 Objective To observe the incidence rate of systemic diseases among the psoriasis inpatients and the rele- vant factors. Methods Total of 75 psoriasis inpatients were selected as the observation group and 92 neuro- dermatitis inpatients(2008.01 -2012. 12) as the control group. The incidence rate of systemic diseases be- tween the two groups and the revelance of smoking, drinking and the course were analysed by the SPSS18.0 statistical software. Results There were 40 psoriasis inpatients combined with systemic diseasees and 35 neurodermatitis inpatients, the observation group had a significantly higher incidence of systemic diseases than the control group ( P 〈 0. 05 ). Smoking, drinking and the course have not the statistical difference be- tween the two groups (P = 0. 687, 0. 951,0. 845 ) , but the difference of age has the statistical difference ( P = 0. 029). Conclusion Psoriasis is closely associated with systemic diseases, and smoking, drinking and age may be the risk factors.
作者 黄蓉 邓晓红
出处 《中国皮肤性病学杂志》 CAS 北大核心 2013年第11期1122-1123,共2页 The Chinese Journal of Dermatovenereology
关键词 银屑病 高血脂 高血压 糖尿病 吸烟 饮酒 Psoriasis neurodermatitis Systemic diseases Smoking Drinking
  • 相关文献

参考文献10

二级参考文献47

  • 1冯峥,葛萍,李恒进,黎燕.银屑病患者血清TNFα浓度及其在皮损中的表达研究[J].军医进修学院学报,2005,26(2):81-83. 被引量:18
  • 2王爱民.银屑病病人对自身疾病及自我保护水平的认识[J].临床皮肤科杂志,1995,24(5):294-296. 被引量:2
  • 3郑敏.银屑病发病机制研究中若干问题的思考[J].中华皮肤科杂志,2006,39(3):121-123. 被引量:104
  • 4Kastelan M,Massari LP, Pasic A,et al. New trends in the immunop- athogenesis of psoriasis[J].Acta Dermatovenerol Croat,2004,12(1): 26-29.
  • 5Chodorowska G.Plasma concentrations of IFN-r and TNF- a in psoriatic patients before and after Local treatment with dithranol ointment [J].J Eur Acad Der matol Venereol, 1998,10(2): 147-151.
  • 6Schopf RE,Aust H,Knop J. Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor alpha, infliaimab[J]. J Am aead Dermatok,2002,46(6):886-891.
  • 7Gisondi P, Gubinelli E,Cocuroccia B,et al. Targeting Tumor Necrosis Factor- alpha in the Therapyof Psoriasis[J]. CurrDrug Targets Inflamm Allergy,2004,3 (2): 175-183.
  • 8Schottelius AJ,Moldawer LL,Dinarello CA,et al. Biology of tumor necrosis factor- alpha - implications for psoriasis[J]. Exp Dermato 1,2004,13 (4): 193 -222.
  • 9Griffiths CE,Barker JN.Pathogenesis and clinical features of psoriasis[J].Lancet,2007,370(9583):263-271.
  • 10Gisondi P,Tessari G,Conti A,et al.Prevalence of metabolic syndrome in patients with psoriasis:a hospital-based case-control study[J].Br J Dermatol,2007,157(1):68-73.

共引文献75

同被引文献5

引证文献1

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部